M Krámer - Concepedia

Author

M Krámer

Also Known As

M H H Kramer, M H Kramer, M Kramer, M Krámer, M Krämer, M. H. H. Kramer, M. Kramer, M.H.H. Kramer, MARK KRAMER, Mark H Kramer

Publications

1.8K

Citations

H-Index

Concepts

All Affiliations

Leiden University Erasmus University Rotterdam Leiden University Medical Center Mitre (United States)

About

M Krámer is an author at Leiden University specializing in medicine, immunology, and hematology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	3	3	63
2	Arts	1	1	26
3	Engineering	1	1	26
4	Blood Transplantation	1	1	13
5	Cell Biology	1	1	13

M Krámer

Publications

1.7K

Citations

H-Index

Page 1

	Year	Citations
Clinical Relevance of BCL2, BCL6, and MYC Rearrangements in Diffuse Large B-Cell Lymphoma M Krámer, Jos Hermans, E.R. Wijburg, Blood	1998	488
Synthea: An approach, method, and software mechanism for generating synthetic patients and the synthetic electronic health care record Jason Walonoski, M Krámer, Joseph C. Nichols, Journal of the American Medical Informatics Association	2017	399
Clinical significance of bcl2 and p53 protein expression in diffuse large B-cell lymphoma: a population-based study. M Krámer, J. Hermans, Jefferson Parker, Journal of Clinical Oncology	1996	205
Mantle-cell lymphoma: a population-based clinical study. Gerjo A. Velders, Hanneke C. Kluin‐Nelemans, Carla J. de Boer, Journal of Clinical Oncology	1996	188
CHOP Compared With CHOP Plus Granulocyte Colony-Stimulating Factor in Elderly Patients With Aggressive Non-Hodgkin’s Lymphoma Jeanette K. Doorduijn, Bronno van der Holt, Gustaaf W. van Imhoff, Journal of Clinical Oncology	2003	168
Clinical Relevance of BCL2, BCL6, and MYC Rearrangements in Diffuse Large B-Cell Lymphoma M Krámer, Jos Hermans, E.R. Wijburg, Blood	1998	59
De novo acute B-cell leukemia with translocation t(14;18): an entity with a poor prognosis. M Krámer, S Raghoebier, G.C. Beverstock, PubMed	1991	54
Addition of cyclosporin A to the combination of mitoxantrone and etoposide to overcome resistance to chemotherapy in refractory or relapsing acute myeloid leukaemia: Simon Daenen, Bronno van der Holt, Gregor Verhoef, Leukemia Research Hematological MalignancyMedicineHematologyImmunologyPharmacology	2004	38
Imatinib-induced pseudoporphyria L. Timmer‐de Mik, Sylvia H. Kardaun, M Krámer, Clinical and Experimental Dermatology	2008	34
Gastric lymphomas compared with lymph node lymphomas in a population-based registry differ in stage distribution and dissemination patterns but not in patient survival Augustinus D. G. Krol, J. Hermans, M Krámer, Cancer	1997	33

Page 1